Anti-PBM Bills Would Take Away the Choice and Flexibility Employers Say They Value

Employers overwhelmingly say they’re satisfied with their PBM, describe PBM contracts as “transparent,” and value a wide range of choices from their PBMs

A recent survey of 700 employers highlights why so many employers choose to work with a pharmacy benefit company (PBM):

  • 89% of employers say their PBM is valuable in helping their organization offer affordable benefits.[1]
  • 9 in 10 employers who receive rebates from PBMs use those rebates to the benefit of employees, including lowering employee spending on benefits and enhancing coverage.[1]

No employer has to contract with a pharmacy benefit company, but most choose to because they want help designing quality, affordable prescription drug coverage for their employees. Across the country, employers are speaking out in local newspapers against policies that would threaten pharmacy benefits for employees and raise health care costs.

The Big Pharma-backed “delinking” policy removes market-based incentives for pharmacy benefit companies to secure the deepest discounts on drugs, including those with extraordinarily high list prices.

  • A recent analysis finds imposing this policy in the commercial market would reduce savings for employers that could otherwise fund benefits, lower health care costs for their employees or support wellness programs that meet the unique needs of their workforce. This would increase premiums for over 176 million patients, with increases as high as $26.6 billion, all while handing Big Pharma a $22 billion bailout – in just the commercial market.[2]

 

America’s Employers on the Value of PBMs In Their Own Words…